SMURF2 and nonpapillary renal cell carcinoma: Elevated SMURF2 mRNA levels have been associated with improved outcomes in clear cell renal cell carcinoma (ccRCC), suggesting its potential as a biomarker for prognosis and a therapeutic target (12, 13).